Grifols (GRFS) Raw Materials (2010 - 2025)

Grifols (GRFS) reported Raw Materials of $1.1 billion for Q4 2025, up 4.15% on a YoY basis from $1.0 billion in Q4 2024, and up 4.15% quarter-over-quarter from $1.0 billion in Q4 2024.

Grifols (GRFS) Raw Materials (2010 - 2025) Analysis & Trends

Grifols has reported Raw Materials for 12 years, with the latest figure at $1.1 billion in Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials rose 4.15% year-over-year to $1.1 billion; the trailing twelve-month figure through Dec 2025 stood at $1.1 billion (up 4.15% YoY), and the FY2025 full-year result was $1.1 billion, up 4.15% from the prior year.
  • Raw Materials for Q4 2025 stood at $1.1 billion, up from $1.0 billion in the prior quarter.
  • The five-year high for Raw Materials was $1.2 billion in Q4 2023, with the low at $751.7 million in Q4 2021.
  • Historically, Raw Materials has averaged $1.0 billion across 5 years, with a median of $1.1 billion in 2022.
  • Annual changes were most pronounced in 2022 — Raw Materials soared 44.53% — and 2024, when it dropped 10.98%.
  • Grifols' Raw Materials stood at $751.7 million in 2021, then jumped by 44.53% to $1.1 billion in 2022, then advanced by 8.18% to $1.2 billion in 2023, then fell by 10.98% to $1.0 billion in 2024, then gained by 4.15% to $1.1 billion in 2025.
  • The last three Raw Materials figures came in at $1.1 billion (Q4 2025), $1.0 billion (Q4 2024), and $1.2 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols 6.05 Bn 5.09 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.09 Bn
Dec 31, 2024 1.05 Bn
Dec 31, 2023 1.18 Bn
Dec 31, 2022 1.09 Bn
Dec 31, 2021 751.66 Mn
Dec 31, 2020 709.88 Mn
Dec 31, 2019 847.97 Mn
Dec 31, 2018 738.94 Mn
Dec 31, 2017 534.99 Mn
Dec 31, 2016 457.08 Mn
Dec 31, 2011 -581.60 Mn
Sep 30, 2011 -406.36 Mn
Jun 30, 2011 -251.94 Mn
Dec 31, 2010 413.93 Mn
Sep 30, 2010 -287.29 Mn